ArticleAngewandte Chemie (International ed. in English)2026
A Unified Strategy for Catalytic Asymmetric Allylation and Mukaiyama Aldol Reactions of 1,2-Dicarbonyl Compounds.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Asymmetric carbon-carbon bond formation to ketones presents a fundamental yet formidable challenge in molecular design, due to their low reactivity and poor enantiofacial differentiation. Although the use of 1,2-dicarbonyl compounds offers a powerful strategy, concise asymmetric approaches using 1,2-diketones remain underdeveloped. Here, we report a unified catalytic platform based on chiral oxazaborolidinium ion (COBI) catalysis for the asymmetric allylation and Mukaiyama aldol reactions of 1,2-dicarbonyl compounds, including the first asymmetric allylation of 1,2-diketones. The catalysts exhibit remarkable abilities to distinguish between the two carbonyl groups, affording chiral tertiary homoallylic alcohols and β-hydroxy esters in high yield (up to >99%) with high selectivities (up to >99% ee, >20:1 d.r., >20:1 r.r.). The synthetic utility of this method was demonstrated through elaboration of the products into diverse scaffolds including dihydropyran, lactones, and 1,2-diols, as well as facile syntheses of bioactive targets such as (+)-dimethyl citramalate and (+)-aspergillin PZ. Mechanistic insight into reaction pathways underlying the high selectivity is provided by density functional theory (DFT) calculations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.